Chinese General Practice ›› 2024, Vol. 27 ›› Issue (09): 1102-1108.DOI: 10.12114/j.issn.1007-9572.2023.0450
• Original Research • Previous Articles Next Articles
Received:
2023-08-01
Revised:
2023-10-20
Published:
2024-03-20
Online:
2023-12-19
Contact:
MA Jianjun
通讯作者:
马建军
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0450
组别 | 例数 | 年龄( | 性别(男/女) | 病程[M(P25,P75),年] | H-Y分期[M(P25,P75)] | MDS-UPDRSⅠ [M(P25,P75),分] | MDS-UPDRSⅡ [M(P25,P75),分] | MDS-UPDRSⅢ [M(P25,P75),分] | MDS-UPDRS-总[M(P25,P75),分] |
---|---|---|---|---|---|---|---|---|---|
健康对照组 | 39 | 56.0±6.5 | 15/24 | ||||||
PD组 | 49 | 58.6±6.4 | 20/29 | 2.0(1.0,3.0) | 2(1,2) | 11.0(7.0,14.0) | 8.0(5.0,13.0) | 17.0(10.5,28.5) | 39.0(25.0,49.5) |
χ2(t)值 | 1.964a | 0.500 | |||||||
P值 | 0.053 | 0.823 |
Table 1 Comparison of general clinical data between the two groups
组别 | 例数 | 年龄( | 性别(男/女) | 病程[M(P25,P75),年] | H-Y分期[M(P25,P75)] | MDS-UPDRSⅠ [M(P25,P75),分] | MDS-UPDRSⅡ [M(P25,P75),分] | MDS-UPDRSⅢ [M(P25,P75),分] | MDS-UPDRS-总[M(P25,P75),分] |
---|---|---|---|---|---|---|---|---|---|
健康对照组 | 39 | 56.0±6.5 | 15/24 | ||||||
PD组 | 49 | 58.6±6.4 | 20/29 | 2.0(1.0,3.0) | 2(1,2) | 11.0(7.0,14.0) | 8.0(5.0,13.0) | 17.0(10.5,28.5) | 39.0(25.0,49.5) |
χ2(t)值 | 1.964a | 0.500 | |||||||
P值 | 0.053 | 0.823 |
组别 | 例数 | 浅层毛细血管密度(%) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
A1 ( | A2[M(P25,P75)] | A3[M(P25,P75)] | A4[M(P25,P75)] | A5[M(P25,P75)] | A6[M(P25,P75)] | A7[M(P25,P75)] | A8[M(P25,P75)] | A9[M(P25,P75)] | ||
健康对照组 | 39 | 9.30±4.07 | 47.09 (44.15,51.99) | 42.69 (35.40,44.63) | 48.70 (44.96,51.95) | 44.18 (38.63,47.56) | 44.85 (43.44,46.52) | 47.67 (45.76,51.02) | 43.50 (41.37,46.62) | 51.37 (49.57,53.68) |
PD组 | 49 | 8.74±3.92 | 46.91 (41.81,49.30) | 39.46 (36.49,42.82) | 46.83 (42.77,50.33) | 43.03 (39.09,45.39) | 43.61 (40.68,46.38) | 45.88 (41.43,48.16) | 42.60 (39.31,43.85) | 50.25 (47.59,52.07) |
t(Z)值 | -0.655 | -1.508a | -1.239a | -1.432a | -1.029a | -1.970a | -3.322a | -2.121a | -2.39a | |
P值 | 0.514 | 0.132 | 0.215 | 0.152 | 0.303 | 0.049 | 0.001 | 0.034 | 0.017 | |
组别 | 视网膜层厚度( | |||||||||
A1 | A2 | A3 | A4 | A5 | A6 | A7 | A8 | A9 | ||
健康对照组 | 246.87±21.06 | 330.94±17.82 | 315.27±15.69 | 328.24±17.92 | 330.61±17.97 | 294.09±14.30 | 275.52±14.25 | 279.77±14.35 | 312.01±15.65 | |
PD组 | 243.82±17.24 | 322.69±15.47 | 308.44±14.43 | 320.12±15.53 | 321.78±15.76 | 283.92±12.38 | 268.25±11.35 | 270.66±12.31 | 299.06±14.35 | |
t(Z)值 | -0.747 | -2.322 | -2.121 | -2.275 | -2.456 | -3.571 | -2.666 | -3.204 | -4.038 | |
P值 | 0.457 | 0.023 | 0.037 | 0.025 | 0.016 | 0.001 | 0.009 | 0.002 | <0.001 | |
组别 | 节细胞复合体层厚度(μm) | |||||||||
A1( | A2( | A3( | A4( | A5( | A6[M(P25,P75)] | A7[M(P25,P75)] | A8[M(P25,P75)] | A9( | ||
健康对照组 | 34.09±9.51 | 115.44±10.23 | 101.74±8.17 | 115.96±11.11 | 109.47±10.20 | 103.61(99.18,108.95) | 88.71(82.06,92.08) | 102.85(98.20,110.13) | 121.57±10.17 | |
PD组 | 34.23±7.75 | 111.93±10.06 | 98.93±8.67 | 113.04±9.37 | 105.92±9.77 | 102.75(96.57,107.53) | 87.43(81.68,90.96) | 100.40(95.42,105.09) | 116.33±9.94 | |
t(Z)值 | 0.08 | -1.616 | -1.552 | -1.338 | -1.664 | -1.390a | -1.155a | -1.693a | -2.430 | |
P值 | 0.937 | 0.110 | 0.124 | 0.184 | 0.100 | 0.164 | 0.248 | 0.091 | 0.017 | |
组别 | 神经纤维层厚度(μm) | |||||||||
A1( | A2( | A3[M(P25,P75)] | A4( | A5( | A6( | A7( | A8( | A9[M(P25,P75)] | ||
健康对照组 | 11.78±2.12 | 28.45±3.31 | 19.05(17.77,20.38) | 29.42±3.67 | 24.11±2.72 | 45.56±4.49 | 25.62±4.20 | 48.44±5.64 | 53.09(50.21,59.73) | |
PD组 | 12.00±1.25 | 28.11±3.34 | 18.53(17.76,19.82) | 29.04±3.19 | 23.76±2.49 | 44.95±5.22 | 23.24±3.46 | 46.92±4.93 | 52.89(48.06,56.43) | |
t(Z)值 | 0.602 | -0.482 | -0.643a | -0.511 | -0.637 | -0.679 | -2.850 | -1.352 | -1.441a | |
P值 | 0.549 | 0.631 | 0.520 | 0.610 | 0.526 | 0.499 | 0.005 | 0.180 | 0.150 | |
组别 | 视网膜外层厚度( | |||||||||
A1 | A2 | A3 | A4 | A5 | A6 | A7 | A8 | A9 | ||
健康对照组 | 185.20±11.08 | 170.74±9.48 | 173.29±8.29 | 168.08±9.17 | 177.56±9.71 | 151.83±7.94 | 149.67±7.60 | 141.27±7.69 | 150.40±8.11 | |
PD组 | 182.18±9.76 | 166.78±7.69 | 170.18±7.35 | 163.88±7.38 | 172.99±7.87 | 146.48±7.19 | 145.77±7.13 | 136.86±6.77 | 144.70±7.53 | |
t(Z)值 | -1.356 | -2.161 | -1.866 | -2.380 | -2.437 | -3.314 | -2.473 | -2.857 | -3.412 | |
P值 | 0.179 | 0.033 | 0.065 | 0.020 | 0.017 | 0.001 | 0.015 | 0.005 | 0.001 |
Table 2 Comparison of characteristics of retinal changes between the two groups
组别 | 例数 | 浅层毛细血管密度(%) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
A1 ( | A2[M(P25,P75)] | A3[M(P25,P75)] | A4[M(P25,P75)] | A5[M(P25,P75)] | A6[M(P25,P75)] | A7[M(P25,P75)] | A8[M(P25,P75)] | A9[M(P25,P75)] | ||
健康对照组 | 39 | 9.30±4.07 | 47.09 (44.15,51.99) | 42.69 (35.40,44.63) | 48.70 (44.96,51.95) | 44.18 (38.63,47.56) | 44.85 (43.44,46.52) | 47.67 (45.76,51.02) | 43.50 (41.37,46.62) | 51.37 (49.57,53.68) |
PD组 | 49 | 8.74±3.92 | 46.91 (41.81,49.30) | 39.46 (36.49,42.82) | 46.83 (42.77,50.33) | 43.03 (39.09,45.39) | 43.61 (40.68,46.38) | 45.88 (41.43,48.16) | 42.60 (39.31,43.85) | 50.25 (47.59,52.07) |
t(Z)值 | -0.655 | -1.508a | -1.239a | -1.432a | -1.029a | -1.970a | -3.322a | -2.121a | -2.39a | |
P值 | 0.514 | 0.132 | 0.215 | 0.152 | 0.303 | 0.049 | 0.001 | 0.034 | 0.017 | |
组别 | 视网膜层厚度( | |||||||||
A1 | A2 | A3 | A4 | A5 | A6 | A7 | A8 | A9 | ||
健康对照组 | 246.87±21.06 | 330.94±17.82 | 315.27±15.69 | 328.24±17.92 | 330.61±17.97 | 294.09±14.30 | 275.52±14.25 | 279.77±14.35 | 312.01±15.65 | |
PD组 | 243.82±17.24 | 322.69±15.47 | 308.44±14.43 | 320.12±15.53 | 321.78±15.76 | 283.92±12.38 | 268.25±11.35 | 270.66±12.31 | 299.06±14.35 | |
t(Z)值 | -0.747 | -2.322 | -2.121 | -2.275 | -2.456 | -3.571 | -2.666 | -3.204 | -4.038 | |
P值 | 0.457 | 0.023 | 0.037 | 0.025 | 0.016 | 0.001 | 0.009 | 0.002 | <0.001 | |
组别 | 节细胞复合体层厚度(μm) | |||||||||
A1( | A2( | A3( | A4( | A5( | A6[M(P25,P75)] | A7[M(P25,P75)] | A8[M(P25,P75)] | A9( | ||
健康对照组 | 34.09±9.51 | 115.44±10.23 | 101.74±8.17 | 115.96±11.11 | 109.47±10.20 | 103.61(99.18,108.95) | 88.71(82.06,92.08) | 102.85(98.20,110.13) | 121.57±10.17 | |
PD组 | 34.23±7.75 | 111.93±10.06 | 98.93±8.67 | 113.04±9.37 | 105.92±9.77 | 102.75(96.57,107.53) | 87.43(81.68,90.96) | 100.40(95.42,105.09) | 116.33±9.94 | |
t(Z)值 | 0.08 | -1.616 | -1.552 | -1.338 | -1.664 | -1.390a | -1.155a | -1.693a | -2.430 | |
P值 | 0.937 | 0.110 | 0.124 | 0.184 | 0.100 | 0.164 | 0.248 | 0.091 | 0.017 | |
组别 | 神经纤维层厚度(μm) | |||||||||
A1( | A2( | A3[M(P25,P75)] | A4( | A5( | A6( | A7( | A8( | A9[M(P25,P75)] | ||
健康对照组 | 11.78±2.12 | 28.45±3.31 | 19.05(17.77,20.38) | 29.42±3.67 | 24.11±2.72 | 45.56±4.49 | 25.62±4.20 | 48.44±5.64 | 53.09(50.21,59.73) | |
PD组 | 12.00±1.25 | 28.11±3.34 | 18.53(17.76,19.82) | 29.04±3.19 | 23.76±2.49 | 44.95±5.22 | 23.24±3.46 | 46.92±4.93 | 52.89(48.06,56.43) | |
t(Z)值 | 0.602 | -0.482 | -0.643a | -0.511 | -0.637 | -0.679 | -2.850 | -1.352 | -1.441a | |
P值 | 0.549 | 0.631 | 0.520 | 0.610 | 0.526 | 0.499 | 0.005 | 0.180 | 0.150 | |
组别 | 视网膜外层厚度( | |||||||||
A1 | A2 | A3 | A4 | A5 | A6 | A7 | A8 | A9 | ||
健康对照组 | 185.20±11.08 | 170.74±9.48 | 173.29±8.29 | 168.08±9.17 | 177.56±9.71 | 151.83±7.94 | 149.67±7.60 | 141.27±7.69 | 150.40±8.11 | |
PD组 | 182.18±9.76 | 166.78±7.69 | 170.18±7.35 | 163.88±7.38 | 172.99±7.87 | 146.48±7.19 | 145.77±7.13 | 136.86±6.77 | 144.70±7.53 | |
t(Z)值 | -1.356 | -2.161 | -1.866 | -2.380 | -2.437 | -3.314 | -2.473 | -2.857 | -3.412 | |
P值 | 0.179 | 0.033 | 0.065 | 0.020 | 0.017 | 0.001 | 0.015 | 0.005 | 0.001 |
变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
视网膜层A2厚度 | -0.247 | 0.087 | 8.120 | 0.004 | 0.781(0.659~0.926) |
视网膜层A3厚度 | 0.174 | 0.079 | 4.831 | 0.028 | 1.190(1.019~1.390) |
视网膜外层A2厚度 | -0.290 | 0.110 | 6.925 | 0.009 | 0.748(0.603~0.929) |
视网膜外层A6厚度 | 0.817 | 0.221 | 13.703 | <0.001 | 2.264(1.469~3.490) |
视网膜外层A8厚度 | -0.325 | 0.116 | 7.890 | 0.005 | 0.723(0.576~0.906) |
神经纤维层A7厚度 | -0.524 | 0.136 | 14.919 | <0.001 | 0.592(0.454~0.773) |
浅层毛细血管A7密度 | 0.676 | 0.174 | 15.127 | <0.001 | 1.966(1.399~2.765) |
Table 3 Multivariate Logistic regression analysis of macular retinal structural characteristics in patients with early PD
变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
视网膜层A2厚度 | -0.247 | 0.087 | 8.120 | 0.004 | 0.781(0.659~0.926) |
视网膜层A3厚度 | 0.174 | 0.079 | 4.831 | 0.028 | 1.190(1.019~1.390) |
视网膜外层A2厚度 | -0.290 | 0.110 | 6.925 | 0.009 | 0.748(0.603~0.929) |
视网膜外层A6厚度 | 0.817 | 0.221 | 13.703 | <0.001 | 2.264(1.469~3.490) |
视网膜外层A8厚度 | -0.325 | 0.116 | 7.890 | 0.005 | 0.723(0.576~0.906) |
神经纤维层A7厚度 | -0.524 | 0.136 | 14.919 | <0.001 | 0.592(0.454~0.773) |
浅层毛细血管A7密度 | 0.676 | 0.174 | 15.127 | <0.001 | 1.966(1.399~2.765) |
模型 | 准确度 | AUC | 灵敏度 | 特异度 | 精确度 |
---|---|---|---|---|---|
LR | 0.769 | 0.841 | 0.750 | 0.800 | 0.857 |
KNN | 0.730 | 0.764 | 0.706 | 0.778 | 0.857 |
DT | 0.846 | 0.806 | 0.813 | 0.900 | 0.929 |
RF | 0.731 | 0.766 | 0.733 | 0.727 | 0.786 |
XGBoost | 0.769 | 0.732 | 0.750 | 0.800 | 0.857 |
Table 4 Comparison of overall performance of machine learning models
模型 | 准确度 | AUC | 灵敏度 | 特异度 | 精确度 |
---|---|---|---|---|---|
LR | 0.769 | 0.841 | 0.750 | 0.800 | 0.857 |
KNN | 0.730 | 0.764 | 0.706 | 0.778 | 0.857 |
DT | 0.846 | 0.806 | 0.813 | 0.900 | 0.929 |
RF | 0.731 | 0.766 | 0.733 | 0.727 | 0.786 |
XGBoost | 0.769 | 0.732 | 0.750 | 0.800 | 0.857 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[1] | GUO Tianci, CHEN Jixin, YU Weijie, LIU Aifeng. Recent Developments in the Application of Artificial Intelligence in the Diagnosis and Treatment of Osteoarthritis [J]. Chinese General Practice, 2023, 26(19): 2428-2433. |
[2] | WANG Qiuqin, ZHANG Yutong, XU Yuchen, BAI Yamei, CHEN Hua, JIANG Rongrong, YAN Shuxia, WANG Qing, XU Guihua, XIE Ying, QIAO Chun, YANG Juan. Short-term Clinical Effect of Guasha Combined with Drug Therapy on Idiopathic Parkinson's Disease [J]. Chinese General Practice, 2023, 26(17): 2155-2161. |
[3] | ZHUANG Fei, LI Ping, HE Xing, SHI Yushan, SUN Liping. Risk Factors of Enlarged Perivascular Space and Its Association with Fundus Lesions in Patients with Mild Acute Cerebral Infarction [J]. Chinese General Practice, 2023, 26(14): 1753-1757. |
[4] | ZHANG Yutong, WANG Qiuqin, XU Yuchen, WENG Heng, LIANG Yongqi, WANG Lulu, WANG Qing, XU Guihua. Factors Affecting Pain in Patients with Parkinson's Disease: a Systematic Review [J]. Chinese General Practice, 2023, 26(14): 1766-1774. |
[5] | DONG Linrui, CHANG Qingqing, MA Jianjun, LIU Chuanze, GUO Dashuai, LI Xiaohuan, FAN Yongyan, LI Dongsheng. Correlation between Autonomic Dysfunction and Cognitive Impairment in Patients with Parkinson's Disease [J]. Chinese General Practice, 2023, 26(12): 1450-1455. |
[6] | ZHAO Jiaqi, LIU Wei, TANG Na, WANG Lamei, QU Yuanyuan, XI Dongmei, ZHONG Hua, HE Fang. Role of Calcium-sensing Receptors in Myocardial Remodeling and Retinal Vasculopathy in Rat Models of Hypertension [J]. Chinese General Practice, 2023, 26(05): 576-582. |
[7] | Yongjian WANG, Weijing QI, Yipeng WANG, Sha HUANG, Cong LI, Na WEI, Jie HU. Classification and Comparative Analysis of Prediction Models for Postpartum Depression [J]. Chinese General Practice, 2022, 25(24): 3036-3042. |
[8] | Gen HUANG, Huimin CAO, Gang YU. Novel Developments in Hypomimia in Parkinson's Disease [J]. Chinese General Practice, 2022, 25(20): 2558-2562. |
[9] |
SHI Xiaoxue, ZHENG Jinhua, MA Jianjun, WANG Zhidong, SUN Wenhua, LI Mingjian, HUANG Shen, HU Shiyu, LI Dongsheng.
Risk Factors of Dysphagia in Parkinson's Disease [J]. Chinese General Practice, 2022, 25(06): 669-674. |
[10] |
ZHOU Lijuan, WEN Xianxiu, LYU Qin, JIANG Rong, WU Xingwei, ZHOU Huangyuan, XIANG Chao.
Using Machine Learning to Build an Early Warning Model for the Risk of Severe Airflow Limitation in Patients with Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2022, 25(02): 217-226. |
[11] |
WU Xingwei, LIU Xinyu, LONG Enwu, TONG Rongsheng.
Research Progress of Machine Learning in Clinical Drug Therapy [J]. Chinese General Practice, 2022, 25(02): 254-258. |
[12] | YANG Xu. Differences in Clinical Characteristics when REM Sleep Behavior Disorder Precedes or Comes after the Onset of Parkinson's Disease [J]. Chinese General Practice, 2021, 24(8): 959-963. |
[13] | XU Xiaohui, TIAN Junmei, CAI Weiwei, ZHAO Yongfei, WANG Yupeng, LIU Chao, DUAN Zhihui. Sex-specific Correlations of Fracture Risk with Nutritional Status,Body Composition and Balance Condition in Parkinson's Disease Patients [J]. Chinese General Practice, 2021, 24(36): 4607-4611. |
[14] | ZHANG Xinnan,HUANG Ying,QIN Yao,CUI Jing,GE Xiaoyan,HAN Hongjuan,LIU Long,YU Hongmei. Intermediary Role of Autonomic Dysfunction in the Relationship between Rapid Eye Movement Sleep Behavior Disorder and Severity of Parkinson's Disease [J]. Chinese General Practice, 2021, 24(24): 3060-3065. |
[15] | SHI Qiang,LUO Qin,GONG Qinping,WANG Gang. Effects of rTMS Combined with Hyperbaric Oxygen-acupuncture-rehabilitation Therapy on Motor Function,Serum CRP and Plasma Dopamine in Patients with Parkinson's Disease [J]. Chinese General Practice, 2020, 23(27): 3460-3465. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||